Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001140361-14-020184
Filing Date
2014-05-12
Accepted
2014-05-12 16:29:05
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL CORP. 10-Q A 6-30-2013 form10qa.htm 10-Q/A 974973
2 EXHIBIT 15.1 ex15_1.htm EX-15.1 3739
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 13654
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 8206
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 6912
  Complete submission text file 0001140361-14-020184.txt   6331027

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rptp-20130630.xml EX-101.INS 839608
7 XBRL TAXONOMY EXTENSION SCHEMA rptp-20130630.xsd EX-101.SCH 47853
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20130630_cal.xml EX-101.CAL 53895
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20130630_def.xml EX-101.DEF 166812
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20130630_lab.xml EX-101.LAB 650371
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20130630_pre.xml EX-101.PRE 327819
Mailing Address 5 HAMILTON LANDING SUITE 160 NOVATO CA 94949
Business Address 5 HAMILTON LANDING SUITE 160 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

EIN.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-25571 | Film No.: 14833749
SIC: 2834 Pharmaceutical Preparations